KAREN VAUGHAN: Open Payments
NPI 1376022376 · MONTGOMERY, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$885 in 35 payments from 11 companies in 2025. Trend: 2023 $341 · 2024 $794 · 2025 $885
Food & beverage: $885
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 9 | $213 |
| Calliditas Therapeutics US Inc. | 7 | $200 |
| Novartis Pharmaceuticals Corporation | 4 | $121 |
| Travere Therapeutics, Inc. | 3 | $89 |
| AKEBIA THERAPEUTICS INC | 3 | $83 |
| Ardelyx, Inc. | 2 | $50 |
| OPKO Pharmaceuticals, LLC | 2 | $37 |
| Fresenius USA Marketing, Inc. | 2 | $32 |
| Novo Nordisk Inc | 1 | $25 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $19 |
Products named: Kerendia, TARPEYO, Fabhalta, Auryxia, IBSRELA, RAYALDEE, VELPHORO, Vafseo.
Industry payments across AL — which companies pay providers there.
